Cell to Sell

CELL TO SELL unpacks the billion-dollar world of life sciences, biotechnology, and precision medicine with striking clarity and depth. As gene sequencing becomes cheaper and AI reshapes diagnostics, a seismic shift is underway—where healthcare is no longer reactive but predictive, personalized, and data-driven.

But behind this promise lies a challenging business landscape. From FDA approvals to intellectual property battles, from investor skepticism to ethical dilemmas over genetic data, building a company in this space demands more than just innovation—it demands vision, resilience, and strategic acumen.

This book is a vital guide for biotech entrepreneurs, investors, engineers, scientists, and policymakers. It reveals how next-gen wellness and medical breakthroughs are built—from lab bench to boardroom—and how stakeholders can navigate the complex maze of regulations, business models, and technological disruption. Whether you're launching a biotech startup, investing in personalized therapeutics, or shaping healthcare policy, CELL TO SELL provides the blueprint to decode, build, and thrive in the business of life itself.